Andrew Tepperman is a vice president in CRA’s Life Sciences Practice. Dr. Tepperman has deep experience conducting economic analyses in legal matters involving intellectual property, antitrust, and other commercial disputes, including international arbitrations. Within the life sciences sector, he has had many engagements involving damages assessment for patent and trade secret infringement, ANDA litigation, patent settlement agreements, monopolization, and breach of contract claims. He has provided expert testimony in Canadian and U.S. court proceedings.
Before joining CRA in 2001, Dr. Tepperman lectured at the University of Toronto and conducted research funded by Industry Canada on the international determinants of patenting. His doctoral dissertation, entitled “The Implications of Intellectual Property Rights for Firm Strategy and Organizational Choice,” was completed in 2001.
PhD, Economics, University of Toronto